Morgan Stanley Upgrades Nevro Corp (NVRO) Two-Notches to Overweight; Positive on New Platform
Tweet Send to a Friend
Morgan Stanley analyst David Lewis upgraded Nevro Corp (NYSE: NVRO) from Underweight to Overweight with a price target of $70.00 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
